Home
About
Overview
Sharing Data
ORCID
Help
History (1)
TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML.
TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML. Blood Adv. 2022 05 10; 6(9):2847-2853.
View in:
PubMed
subject areas
Humans
Karyotype
Leukemia, Myeloid, Acute
Mutation
Myelodysplastic Syndromes
Neoplasms, Second Primary
Prognosis
Tumor Suppressor Protein p53
authors with profiles
Daniel Arber